mixed urinary incontinence
Jump to navigation
Jump to search
Introduction
The combination, in a patient, of urge urinary incontinence & stress urinary incontinence
Clinical manifestations
Management
- see urinary incontinence for general measures
- pelvic floor exercises[2]
- bladder retraining: (cognitively intact patients)
- patient gradually lengthens time between voidings[2]
- tricyclic antidepressants if refractory to non-pharmaceutical measures
- surgical mesh midurethral sling procedures vs intradetrusal 100-U onabotulinumtoxinA (Botox) injections
- symptomatic improvement similar
- worsening urge symptoms at 12 months similar (20%)
- repeat Botox injections 3-6 months after initial injections
- Botox injections are short, low-risk, outpatient cystoscopy procedures[3]
More general terms
Additional terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 14, American College of Physicians, Philadelphia 2006
- ↑ 2.0 2.1 2.2 Qaseem A, Dallas P, Forciea MA et al Nonsurgical Management of Urinary Incontinence in Women: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2014;161(6):429-440 <PubMed> PMID: https://pubmed.ncbi.nlm.nih.gov/25222388 <Internet> http://annals.org/article.aspx?articleid=1905131
- ↑ 3.0 3.1 Harvie HS, Menefee SA, Richter HE, et al. National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Midurethral sling vs onabotulinumtoxinA in females with urinary incontinence: The MUSA randomized clinical trial. JAMA. 2025 Jun 3;333(21):1887-1896 PMID: https://pubmed.ncbi.nlm.nih.gov/40323617 PMCID: PMC12053799 (available on 2025-11-05)